Therapeutic effects of Nigella sativa on chronic HAART- Induced hyperinsulinemia in rats

Canadian Journal of Physiology and Pharmacology

Volumn 87, Issue 4, 2009, Pages 300-309

  Chandra, Surabhi ^a   Murthy, Subramanyam N ^a   Mondal, Debasis ^a   Agrawal, Krishna C ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Black seed oil; Haart drugs; Hyperinsulinemia; Ins 1 cells; Long term exposure; Pancreatic islets; Rats; Therapeutics

Indexed keywords

BLACK SEED OIL; C PEPTIDE; CHOLESTEROL; EFAVIRENZ; ESSENTIAL OIL; INSULIN; NELFINAVIR; THYMOQUINONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLACK CUMIN; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BENZOQUINONES; BLOOD GLUCOSE; CHOLESTEROL; HIV PROTEASE INHIBITORS; HYPERINSULINISM; INSULIN; ISLETS OF LANGERHANS; NELFINAVIR; NIGELLA SATIVA; PHYTOTHERAPY; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

EID: 65249091950     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y09-014     Document Type: Article

References (44)

1. Badary, O.A., Abdel-Naim, A.B., Abdel-Wahab, M.H., and Hamada, F.M. 2000. The influence of thymoquinone on doxorubicin-in- duced hyperlipidemic nephropathy in rats. Toxicology, 143: 219-226. doi:10.1016/S0300-483X(99) 00179-1. PMID:10755708.
2. Balani, S.K., Kauffman, L.R., deLuna, F.A., and Lin, J.H. 1999. Nonlinear pharmacokinetics of efavirenz (DMP-266), a potent HIV-1 reverse transcriptase inhibitor, in rats and monkeys. Drug Metab. Dispos. 27: 41-45. PMID:9884307.
3. Bamosa, A.O., Ali, B.A., and Al-Hawsawi, Z.A. 2002. The effect of thymoquinone on blood lipids in rats. Indian J. Physiol. Pharmacol. 46: 195-201. PMID:12500494.
4. Beatty, O.L., Bell, P.M., Hadden, D.R., Atkinson, A.B., and Kennedy, L. 1995. Insulin and C-peptide secretion in non-insulin-dependent diabetes mellitus and its response to dietary therapy. QJM, 88: 257-262. PMID:7796075.
5. Beatty, G., Khalili, M., Abbasi, F., Chu, J., Reaven, G.M., Rosen, A., et al. 2003. Quantification of insulin-mediated glucose disposal in HIV-infected individuals: comparison of patients treated and untreated with protease inhibitors. J. Acquir. Immune Defic. Syndr. 33: 34-40. PMID:12792353.
6. Behrens, G., Dejam, A., Schmidt, H., Balks, H.J., Brabant, G., Kor- ner, T., et al. 1999. Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors. AIDS, 13: F63-F70. doi:10.1097/00002030- 199907090-00001. PMID:10416516.
7. Ben-Romano, R., Rudich, A., Tirosh, A., Potashnik, R., Sasaoka, T., Riesenberg, K., et al. 2004. Nelfinavir- induced insulin resistance is associated with impaired plasma membrane recruitment of the PI 3-kinase effectors Akt/PKB and PKC-zeta. Diabetologia, 47:1107-1117. doi:10.1007/s00125-004-1408-5. PMID: 15168016.
8. Burger, D., Hugen, P., Reiss, P., Gyssens, I., Schneider, M., Kroon, F., et al. 2003. Therapeutic drug monitoring of nelfinavir and in- dinavir in treatment-naive HIV-1-infected individuals. AIDS, 17:1157-1165. doi:10.1097/00002030-200305230-00007. PMID: 12819517.
9. Burns- Naas, L.A., Zorbas, M., Jessen, B., Evering, W., Stevens, G., Ivett, J.L., et al. 2005. Increase in thyroid follicular cell tumors in nelfinavir- treated rats observed in a 2-year carcinogenicity study is consistent with a rat-specific mechanism of thyroid neoplasia. Hum. Exp. Toxicol. 24: 643-654. doi:10.1191/ 0960327105ht568oa. PMID:16408618.
10. Calza, L., Manfredi, R., and Chiodo, F. 2004. Insulin resistance and diabetes mellitus in HIV-infected patients receiving antiretro- viral therapy. Metab. Syndr. Relat. Disord. 2: 241-250. doi:10. 1089/met.2004.2.241. PMID:18370693.
11. Carper, M.J., Cade, W.T., Cam, M., Zhang, S., Shalev, A., Yara- sheski, K.E., and Ramanadham, S. 2008. HIV-protease inhibitors induce expression of suppressor of cytokine signaling-1 in insulin-sensitive tissues and promote insulin resistance and type 2 diabetes mellitus. Am. J. Physiol. Endocrinol. Metab. 294:E558-E567. doi:10.1152/ajpendo.00167.2007. PMID:18171911.
12. Chai, H., Yan, S., Lin, P., Lumsden, A.B., Yao, Q., and Chen, C. 2005. Curcumin blocks HIV protease inhibitor ritonavir-induced vascular dysfunction in porcine coronary arteries. J. Am. Coll. Surg. 200: 820-830. doi:10.1016/j.jamcollsurg.2005.02.030. PMID:15922191.
13. Currier, J.S., Taylor, A., Boyd, F., Dezii, C.M., Kawabata, H., Burtcel, B., et al. 2003. Coronary heart disease in HIV-infected individuals. J. Acquir. Immune Defic. Syndr. 33: 506-512. PMID:12869840.
14. Darko, D., Dornhorst, A., Kelly, F.J., Ritter, J.M., and Chowienc- zyk, P.J. 2002. Lack of effect of oral vitamin C on blood pressure, oxidative stress and endothelial function in Type II diabetes. Clin. Sci. (Lond.), 103: 339-344. PMID:12241530.
15. Deveaud, C., Beauvoit, B., Reynaud, A., and Bonnet, J. 2007. Site- specific reduction of oxidative and lipid metabolism in adipose tissue of 3'-azido-3'-deoxythymidine-treated rats. Antimicrob. Agents Chemother. 51: 583-590. doi:10.1128/AAC.01078-06. PMID:17158934.
16. Dube, M.P. 2001. Lipodystrophy and insulin resistance in patients with HIV. J. Acquir. Immune Defic. Syndr. 27: 506-507. PMID:11511829.
17. El- Dakhakhny, M., Mady, N., Lembert, N., and Ammon, H.P. 2002. The hypoglycemic effect of Nigella sativa oil is mediated by extrapancreatic actions. Planta Med. 68: 465-466. doi:10. 1055/s-2002-32084. PMID:12058330.
18. El- Mahmoudy, A., Shimizu, Y., Shiina, T., Matsuyama, H., El- Sayed, M., and Takewaki, T. 2005. Successful abrogation by thy- moquinone against induction ofdiabetes mellitus with streptozoto- cin via nitric oxide inhibitory mechanism. Int. Immunopharmacol. 5: 195-207. doi:10.1016/j.intimp.2004. 09.001. PMID:15589481.
19. Fararh, K.M., Shimizu, Y., Shiina, T., Nikami, H., Ghanem, M.M., and Takewaki, T. 2005. Thymoquinone reduces hepatic glucose production in diabetic hamsters. Res. Vet. Sci. 79: 219-223. doi:10.1016/j.rvsc.2005.01.001. PMID:16054891.
20. Hadigan, C., Meigs, J.B., Corcoran, C., Rietschel, P., Piecuch, S., Basgoz, N., et al. 2001. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin. Infect. Dis. 32: 130-139. doi:10.1086/317541. PMID:11118392. Hajhashemi, V., Ghannadi, A., and Jafarabadi, H. 2004. Black cumin seed essential oil, as a potent analgesic and antiinflamma- tory drug. Phytother. Res. 18: 195-199. doi:10.1002/ptr.1390. PMID:15103664.
21. Hruz, P.W. 2006. Molecular mechanisms for altered glucose homeostasis in HIV infection. Am. J. Infect. Dis. 2: 187-192. PMID:17186064.
22. Khattab, M.M., and Nagi, M.N. 2007. Thymoquinone supplementation attenuates hypertension and renal damage in nitric oxide deficient hypertensive rats. Phytother. Res. 21: 410-414. doi:10. 1002/ptr.2083. PMID:17236176.
23. Koster, J.C., Remedi, M.S., Qiu, H., Nichols, C.G., and Hruz, P.W. 2003. HIV protease inhibitors acutely impair glucose-stimulated insulin release. Diabetes, 52: 1695-1700. doi:10.2337/diabetes. 52.7.1695. PMID:12829635.
24. Mondal, D., Pradhan, L., Ali, M., and Agrawal, K.C. 2004. HAART drugs induce oxidative stress in human endothelial cells and increase endothelial recruitment of mononuclear cells: exacerbation by inflammatory cytokines and amelioration by antioxidants. Cardiovasc. Toxicol. 4: 287-302. doi:10.1385/CT:4:3:287. PMID:15470276.
25. Mulligan, K., Grunfeld, C., Tai, V.W., Algren, H., Pang, M., Chernoff, D.N., et al. 2000. Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection. J. Acquir. Immune Defic. Syndr. 23: 35-43. PMID:10708054.
26. Nishikawa, T., Edelstein, D., and Brownlee, M. 2000. The missing link: a single unifying mechanism for diabetic complications. Kidney Int. Suppl. 77: S26-S30. doi:10.1046/j.1523-1755.2000. 07705.x. PMID:10997687.
27. Pereira Fontes, T.M., Santos Simoes, R., Martins Oliveira, F.H., de Jesus Simoes, M., Oliveira-Filho, R.M., Nakamura, M.U., and Kulay, L., Jr. 2007. Extended administration of the association of zidovudine plus ritonavir during rat pregnancy: maternal and fetal effects. Clin. Exp. Obstet. Gynecol. 34: 175-178. PMID:17937095.
28. Periard, D., Telenti, A., and Sudre, P. 1999. Atherogenic dyslipide- mia in HIV-infected individuals treated with protease inhibitors: the Swiss HIV Cohort Study. Circulation, 100: 700-705. PMID:10449690.
29. Rchid, H., Chevassus, H., Nmila, R., Guiral, C., Petit, P., Chokairi, M., and Sauvaire, Y. 2004. Nigella sativa seed extracts enhance glucose-induced insulin release from rat-isolated Langerhans islets. Fundam. Clin. Pharmacol. 18: 525-529. doi:10.1111/j. 1472-8206.2004.00275.x. PMID:15482373.
30. Riddle, T.M., Fichtenbaum, C.J., and Hui, D.Y. 2003. Leptin replacement therapy but not dietary polyunsaturated fatty acid alleviates HIV protease inhibitor-induced dyslipidemia and lipodystrophy in mice. J. Acquir. Immune Defic. Syndr. 33: 564-570. doi:10.1097/00126334-200308150-00003. PMID:12902799.
31. Rudich, A., Vanounou, S., Riesenberg, K., Porat, M., Tirosh, A., Harman- Boehm, I., et al. 2001. The HIV protease inhibitor nel- finavir induces insulin resistance and increases basal lipolysis in 3T3-L1 adipocytes. Diabetes, 50: 1425-1431. doi:10.2337/ diabetes.50.6.1425. PMID:11375344.
32. Savès, M., Raffi, F., and Capeau, J. 2002. Factors related to lipody- strophy and metabolic alterations in patients with human immu- nodeficiency virus infection receiving highly active antiretroviral therapy. Clin. Infect. Dis. 34: 1396-1405. doi:10. 1086/339866. PMID:11981737.
33. Schutt, M., Meier, M., and Meyer, M. 2000. The HIV-1 protease inhibitor indinavir impairs insulin signalling in HepG2 hepatoma cells. Diabetologia, 43: 1145-1148. doi:10.1007/s001250051505. PMID:11043860.
34. Schutt, M., Zhou, J., Meier, M., and Klein, H. 2004. Long-term effects of HIV-1 protease inhibitors on insulin secretion and insulin signaling in INS-1 beta cells. J. Endocrinol. 183: 445-454. doi:10.1677/joe.1.05620. PMID:15590971.
35. Solorzano Santos, F., Gochicoa Rangel, L.G., Palacios Saucedo, G., Vazquez Rosales, G., and Miranda Novales, M.G. 2006. Hyper- triglyceridemia and hypercholesterolemia in human immunodeficiency virus-1-infected children treated with protease inhibitors. Arch. Med. Res. 37: 129-132. doi:10.1016/j.arcmed.2005.05. 013. PMID:16314198.
36. Thompson, M.B., Dunnick, J.K., Sutphin, M.E., Giles, H.D., Irwin, R.D., and Prejean, J.D. 1991. Hematologic toxicity of AZT and ddC administered as single agents and in combination to rats and mice. Fundam. Appl. Toxicol. 17: 159-176. doi:10.1016/ 0272-0590(91)90248-3. PMID:1655546.
37. Tiedge, M., Lortz, S., Drinkgern, J., and Lenzen, S. 1997. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes, 46: 1733-1742. doi:10.2337/diabetes. 46.11.1733. PMID:9356019.
38. Vigouroux, C., Gharakhanian, S., Salhi, Y., Nguyen, T.H., Chev- enne, D., Capeau, J., and Rozenbaum, W. 1999. Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART). Diabetes Metab. 25: 225-232. PMID:10499191.
39. Vincent, S., Tourniaire, F., El Yazidi, C.M., Compe, E., Manches, O., Plannels, R., and Roche, R. 2004. Nelfinavir induces necrosis of 3T3F44-2A adipocytes by oxidative stress. J. Acquir. Immune Defic. Syndr. 37: 1556-1562. doi:10.1097/00126334- 200412150-00003. PMID:15577407.
40. Walli, R., Herfort, O., Michl, G.M., Demant, T., Jager, H., Dieterle, C., et al. 1998. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients. AIDS, 12: F167-F173. doi:10.1097/00002030-199815000-00001. PMID:9814858.
41. Weaver, J.G., Tarze, A., Moffat, T.C., Lebras, M., Deniaud, A., Brenner, C., et al. 2005. Inhibition of adenine nucleotide translo- cator pore function and protection against apoptosis in vivo by an HIV protease inhibitor. J. Clin. Invest. 115: 1828-1838. doi:10.1172/JCI22954. PMID:15937550.
42. Yoshimura, K., Ido, E., Akiyama, H., Kimura, T., Aoki, M., Suzuki, H., et al. 2003. The impact of highly active antiretroviral therapy by the oral route on the CD8 subset in monkeys infected chronically with SHIV 89.6P. J. Virol. Methods, 112: 121-128. doi:10.1016/S0166-0934(03)00201-5. PMID:12951220.
43. Zaoui, A., Cherrah, Y., Lacaille-Dubois, M.A., Settaf, A., Amar- ouch, H., and Hassar, M. 2000. Diuretic and hypotensive effects of Nigella sativa in the spontaneously hypertensive rat. Thera- pie, 55: 379-382. PMID:10967716.
44. Zhou, H., Gurley, E.C., Jarujaron, S., Ding, H., Fang, Y., Xu, Z., et al. 2006. HIV protease inhibitors activate the unfolded protein response and disrupt lipid metabolism in primary hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 291: G1071-G1080. doi:10.1152/ajpgi.00182.2006. PMID:16861219.